| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pheromone receptor activity | 5.96e-06 | 6 | 135 | 3 | GO:0016503 | |
| GeneOntologyMolecularFunction | monoamine oxidase activity | 1.36e-04 | 3 | 135 | 2 | GO:0097621 | |
| GeneOntologyMolecularFunction | peptidase activity | HGFAC PGA4 ADAM19 NRDC PRSS37 PGA5 ADAMTS12 KLK4 APH1A AOPEP ADAM5 USP3 PGA3 PCSK9 | 1.41e-04 | 654 | 135 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | HGFAC PGA4 ADAM19 NRDC PRSS37 PGA5 ADAMTS12 KLK4 ADAM5 PGA3 PCSK9 | 1.66e-04 | 430 | 135 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 2.70e-04 | 4 | 135 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | pheromone binding | 4.48e-04 | 5 | 135 | 2 | GO:0005550 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 9.46e-06 | 7 | 137 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 4.37e-05 | 11 | 137 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | external encapsulating structure | ADAM19 WNT2 EMILIN3 WNT4 PKHD1L1 ADAMTS12 FREM2 FBN2 FCGBP PKM GPC5 LGR6 TNXB | 3.96e-04 | 658 | 137 | 13 | GO:0030312 |
| HumanPheno | Precocious atherosclerosis | 2.98e-06 | 12 | 47 | 4 | HP:0004416 | |
| HumanPheno | Premature arteriosclerosis | 3.99e-05 | 8 | 47 | 3 | HP:0005177 | |
| HumanPheno | Aortic atherosclerotic lesion | 5.95e-05 | 9 | 47 | 3 | HP:0012397 | |
| HumanPheno | Proximal upper limb muscle hypertrophy | 8.33e-05 | 2 | 47 | 2 | HP:0040266 | |
| HumanPheno | Upper limb muscle hypertrophy | 8.33e-05 | 2 | 47 | 2 | HP:0040265 | |
| Domain | Vmron_rcpt_1 | 3.49e-06 | 5 | 133 | 3 | IPR004072 | |
| Domain | V1R | 3.49e-06 | 5 | 133 | 3 | PF03402 | |
| Domain | Aspartic_peptidase_N | 1.21e-05 | 7 | 133 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.21e-05 | 7 | 133 | 3 | PF07966 | |
| Domain | EGF_1 | 1.46e-05 | 255 | 133 | 10 | PS00022 | |
| Domain | EGF_2 | 2.04e-05 | 265 | 133 | 10 | PS01186 | |
| Domain | Sushi | 3.37e-05 | 52 | 133 | 5 | PF00084 | |
| Domain | CCP | 4.06e-05 | 54 | 133 | 5 | SM00032 | |
| Domain | Aspartic_peptidase_A1 | 4.08e-05 | 10 | 133 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 4.08e-05 | 10 | 133 | 3 | IPR033121 | |
| Domain | Asp | 4.08e-05 | 10 | 133 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 4.08e-05 | 10 | 133 | 3 | PS51767 | |
| Domain | SUSHI | 4.85e-05 | 56 | 133 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 5.28e-05 | 57 | 133 | 5 | IPR000436 | |
| Domain | EGF_extracell | 6.77e-05 | 60 | 133 | 5 | IPR013111 | |
| Domain | EGF_2 | 6.77e-05 | 60 | 133 | 5 | PF07974 | |
| Domain | - | 7.41e-05 | 12 | 133 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 7.41e-05 | 12 | 133 | 3 | PS00141 | |
| Domain | EGF-like_dom | 7.46e-05 | 249 | 133 | 9 | IPR000742 | |
| Domain | Aspartic_peptidase_AS | 9.58e-05 | 13 | 133 | 3 | IPR001969 | |
| Domain | EGF-like_CS | 1.07e-04 | 261 | 133 | 9 | IPR013032 | |
| Domain | Flavin_amine_oxidase | 1.50e-04 | 3 | 133 | 2 | IPR001613 | |
| Domain | Peptidase_aspartic_dom | 2.23e-04 | 17 | 133 | 3 | IPR021109 | |
| Domain | EGF | 2.83e-04 | 235 | 133 | 8 | SM00181 | |
| Domain | EGF_3 | 2.83e-04 | 235 | 133 | 8 | PS50026 | |
| Domain | MFS_dom | 3.97e-04 | 134 | 133 | 6 | IPR020846 | |
| Domain | CUB | 4.06e-04 | 49 | 133 | 4 | PF00431 | |
| Domain | CUB | 4.39e-04 | 50 | 133 | 4 | SM00042 | |
| Domain | ABC2_membrane | 4.96e-04 | 5 | 133 | 2 | PF01061 | |
| Domain | ABC_2_trans | 4.96e-04 | 5 | 133 | 2 | IPR013525 | |
| Domain | - | 5.11e-04 | 52 | 133 | 4 | 2.60.120.290 | |
| Domain | CUB | 5.49e-04 | 53 | 133 | 4 | PS01180 | |
| Domain | CUB_dom | 7.25e-04 | 57 | 133 | 4 | IPR000859 | |
| Domain | - | 7.41e-04 | 6 | 133 | 2 | 3.90.1290.10 | |
| Domain | PbH1 | 7.41e-04 | 6 | 133 | 2 | SM00710 | |
| Domain | PbH1 | 7.41e-04 | 6 | 133 | 2 | IPR006626 | |
| Domain | IPT | 9.11e-04 | 27 | 133 | 3 | SM00429 | |
| Domain | Plectin | 1.03e-03 | 7 | 133 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.03e-03 | 7 | 133 | 2 | IPR001101 | |
| Domain | PLEC | 1.03e-03 | 7 | 133 | 2 | SM00250 | |
| Domain | MFS | 1.05e-03 | 108 | 133 | 5 | PS50850 | |
| Domain | Pectin_lyase_fold/virulence | 1.37e-03 | 8 | 133 | 2 | IPR011050 | |
| Domain | TIG | 1.37e-03 | 31 | 133 | 3 | PF01833 | |
| Domain | IPT | 1.51e-03 | 32 | 133 | 3 | IPR002909 | |
| Domain | Sc_DH/Rdtase_CS | 1.96e-03 | 35 | 133 | 3 | IPR020904 | |
| Domain | IGv | 2.02e-03 | 75 | 133 | 4 | SM00406 | |
| Domain | EGF | 2.08e-03 | 126 | 133 | 5 | PF00008 | |
| Domain | Amino_oxidase | 2.18e-03 | 10 | 133 | 2 | IPR002937 | |
| Domain | Amino_oxidase | 2.18e-03 | 10 | 133 | 2 | PF01593 | |
| Domain | MFS_1 | 2.23e-03 | 77 | 133 | 4 | PF07690 | |
| Domain | MFS | 2.23e-03 | 77 | 133 | 4 | IPR011701 | |
| Domain | - | OBSL1 VSIG10 PKHD1L1 DSCAML1 MST1R BTN3A3 CD7 PTPRJ NFATC4 MYOM2 TNXB LILRB5 | 2.78e-03 | 663 | 133 | 12 | 2.60.40.10 |
| Domain | PP2C_BS | 3.17e-03 | 12 | 133 | 2 | IPR000222 | |
| Domain | PP2C_SIG | 4.33e-03 | 14 | 133 | 2 | SM00331 | |
| Domain | Ig-like_fold | OBSL1 VSIG10 PKHD1L1 DSCAML1 MST1R BTN3A3 CD7 PTPRJ NFATC4 MYOM2 TNXB LILRB5 | 4.60e-03 | 706 | 133 | 12 | IPR013783 |
| Domain | PPM_1 | 4.97e-03 | 15 | 133 | 2 | PS01032 | |
| Domain | fn3 | 6.09e-03 | 162 | 133 | 5 | PF00041 | |
| Domain | ADH_SHORT | 6.38e-03 | 53 | 133 | 3 | PS00061 | |
| Domain | PP2C | 6.38e-03 | 17 | 133 | 2 | IPR015655 | |
| Domain | adh_short | 7.07e-03 | 55 | 133 | 3 | PF00106 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 12906867 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 7926498 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 9561228 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 21455714 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 19800305 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 6.25e-08 | 3 | 139 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 6.25e-08 | 3 | 139 | 3 | 2799289 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 6.25e-08 | 3 | 139 | 3 | 1968039 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 6.25e-08 | 3 | 139 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 6.25e-08 | 3 | 139 | 3 | 2229438 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 6.25e-08 | 3 | 139 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 6.25e-08 | 3 | 139 | 3 | 8244094 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 21407214 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 6774973 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 6.25e-08 | 3 | 139 | 3 | 22304859 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 24004680 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 6.25e-08 | 3 | 139 | 3 | 2227273 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 23034090 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 24125879 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 6.25e-08 | 3 | 139 | 3 | 3554488 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 23521833 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 6.25e-08 | 3 | 139 | 3 | 21989121 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 9855083 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 9797498 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 2478370 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 6.25e-08 | 3 | 139 | 3 | 10675278 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 3780036 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 6.25e-08 | 3 | 139 | 3 | 3839486 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 3467902 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 6.25e-08 | 3 | 139 | 3 | 2892778 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 24383519 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 6.25e-08 | 3 | 139 | 3 | 2831884 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 2032552 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 1812762 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 7923573 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 11793338 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 6.25e-08 | 3 | 139 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 6.25e-08 | 3 | 139 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 6.25e-08 | 3 | 139 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 6.25e-08 | 3 | 139 | 3 | 1956484 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 8540382 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 6.25e-08 | 3 | 139 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 6.25e-08 | 3 | 139 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 6.25e-08 | 3 | 139 | 3 | 21970995 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 20428942 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 9525001 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 7886402 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 17379991 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 21547904 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 2.49e-07 | 4 | 139 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 2.49e-07 | 4 | 139 | 3 | 11915945 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 2.49e-07 | 4 | 139 | 3 | 17136346 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 12698190 | ||
| Pubmed | Evolutionary deterioration of the vomeronasal pheromone transduction pathway in catarrhine primates. | 6.21e-07 | 5 | 139 | 3 | 12826614 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 12900932 | ||
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 22066020 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | PGA4 CPNE8 DSC2 PGA5 ITGB5 SLC2A5 IGLV3-21 FREM2 FCGBP RNH1 PTPRJ PKM C7 TNXB PGA3 CNP SOD1 | 1.41e-06 | 1070 | 139 | 17 | 23533145 |
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 19139271 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAOA HECTD4 WNT4 PDE10A ITGB5 JAG2 NLGN3 ABCG1 KLK4 PTPRJ SYNJ2 CLK2 AOPEP FNIP1 AFF1 CSMD1 ABLIM2 USP3 MAML3 | 7.94e-06 | 1489 | 139 | 19 | 28611215 |
| Pubmed | 9.75e-06 | 257 | 139 | 8 | 16335952 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19657584 | ||
| Pubmed | Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. | 1.59e-05 | 2 | 139 | 2 | 21971001 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21971000 | ||
| Pubmed | Effects of genetic depletion of monoamines on somatosensory cortical development. | 1.59e-05 | 2 | 139 | 2 | 12435414 | |
| Pubmed | Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. | 1.59e-05 | 2 | 139 | 2 | 23858446 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21075085 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25398695 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17499243 | ||
| Pubmed | Transcriptional regulation and multiple functions of MAO genes. | 1.59e-05 | 2 | 139 | 2 | 21359973 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2714789 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3197840 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11861643 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32598328 | ||
| Pubmed | Monoamine oxidase A and A/B knockout mice display autistic-like features. | 1.59e-05 | 2 | 139 | 2 | 22850464 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17427196 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33212830 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18092818 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20589923 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21697081 | ||
| Pubmed | Increased baroreceptor response in mice deficient in monoamine oxidase A and B. | 1.59e-05 | 2 | 139 | 2 | 11834493 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 3387449 | ||
| Pubmed | Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. | 1.59e-05 | 2 | 139 | 2 | 17044053 | |
| Pubmed | Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. | 1.59e-05 | 2 | 139 | 2 | 8316221 | |
| Pubmed | Association between monoamine oxidase gene polymorphisms and smoking behavior: A meta-analysis. | 1.59e-05 | 2 | 139 | 2 | 26051160 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16129825 | ||
| Cytoband | 11q12.2 | 2.29e-04 | 39 | 139 | 3 | 11q12.2 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.04e-05 | 57 | 92 | 5 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|ATP binding cassette subfamily G | 2.54e-04 | 5 | 92 | 2 | 811 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.03e-04 | 8 | 92 | 2 | 939 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | CPNE8 WNT2 EMILIN3 RIPOR3 PDE10A ITGB5 ADAMTS12 LMNA PTPRJ SLC16A2 NFATC4 AOPEP GPC5 PEAK1 ABLIM2 USP3 CLCF1 | 2.62e-05 | 878 | 130 | 17 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000 | XIRP1 MAOA MAOB MS4A7 RBM20 STAB1 JAG2 PPP1R3A CIITA SCN7A APOL3 MYOM2 LGR6 C7 FGR ABLIM2 TNXB LILRB5 | 3.42e-05 | 990 | 130 | 18 | PCBC_ctl_geo-heart_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.36e-05 | 104 | 130 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K4 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_500 | XIRP1 MAOB RBM20 STAB1 PPP1R3A SCN7A MYOM2 C7 FGR ABLIM2 TNXB LILRB5 | 5.83e-05 | 499 | 130 | 12 | PCBC_ctl_geo-heart_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CPNE8 MAOA DSC2 MAOB HSDL2 OBSL1 WNT4 VSIG10 CSMD3 ITGB5 SLC18A2 AFF1 PEAK1 USP3 MAML3 | 1.02e-04 | 791 | 130 | 15 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-07 | 194 | 139 | 8 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-07 | 194 | 139 | 8 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-07 | 194 | 139 | 8 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.10e-07 | 198 | 139 | 8 | 1d92b09aeb03a95fa9e221813002045c4f41dd24 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.57e-07 | 164 | 139 | 7 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-06 | 169 | 139 | 7 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 175 | 139 | 7 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 179 | 139 | 7 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-06 | 182 | 139 | 7 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 189 | 139 | 7 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-06 | 190 | 139 | 7 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.54e-06 | 193 | 139 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-06 | 194 | 139 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-06 | 199 | 139 | 7 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-06 | 199 | 139 | 7 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.10e-06 | 199 | 139 | 7 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 3.21e-06 | 200 | 139 | 7 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.60e-06 | 137 | 139 | 6 | a69976938d4e89315ec0be3a332b91ddf3799d65 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.34e-06 | 155 | 139 | 6 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 170 | 139 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 170 | 139 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 171 | 139 | 6 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 171 | 139 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 172 | 139 | 6 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 175 | 139 | 6 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 175 | 139 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-05 | 177 | 139 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-05 | 177 | 139 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 2.11e-05 | 179 | 139 | 6 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.18e-05 | 180 | 139 | 6 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 180 | 139 | 6 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 181 | 139 | 6 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 181 | 139 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.25e-05 | 181 | 139 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-05 | 181 | 139 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.32e-05 | 182 | 139 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.47e-05 | 184 | 139 | 6 | bc0dfe29337f02594e7e0092c9e47dda94b45ad5 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 185 | 139 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-05 | 185 | 139 | 6 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 185 | 139 | 6 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-05 | 185 | 139 | 6 | 538db481c82b02e5d3b8e03b166f754cc936901e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 186 | 139 | 6 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 186 | 139 | 6 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 186 | 139 | 6 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 186 | 139 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 186 | 139 | 6 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 186 | 139 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 187 | 139 | 6 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.70e-05 | 187 | 139 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 188 | 139 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-05 | 188 | 139 | 6 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-05 | 188 | 139 | 6 | 59d5c7b147af118442adadf708ce2d1422b1e9aa | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-05 | 188 | 139 | 6 | 2e268d8091e25d50bf05f26517d3ceb583801fd4 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 188 | 139 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 188 | 139 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 189 | 139 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 2.87e-05 | 189 | 139 | 6 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 189 | 139 | 6 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 189 | 139 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 189 | 139 | 6 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.87e-05 | 189 | 139 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-05 | 190 | 139 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 190 | 139 | 6 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-05 | 190 | 139 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | wk_08-11-Epithelial-PNS-Early_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 190 | 139 | 6 | 8190674a48607984726974765aafbca116f437e0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.13e-05 | 192 | 139 | 6 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.13e-05 | 192 | 139 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 192 | 139 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 193 | 139 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 3.22e-05 | 193 | 139 | 6 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.22e-05 | 193 | 139 | 6 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | wk_08-11-Hematologic-Myeloid-CX3CR1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.22e-05 | 193 | 139 | 6 | afc20433b5abc9b430751a2aa8d93b0fd136a888 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-05 | 193 | 139 | 6 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 193 | 139 | 6 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 194 | 139 | 6 | a516839871c4e9683093a1c07b72c682f9ecbb3d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 139 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.32e-05 | 194 | 139 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.32e-05 | 194 | 139 | 6 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.42e-05 | 195 | 139 | 6 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.42e-05 | 195 | 139 | 6 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 195 | 139 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.42e-05 | 195 | 139 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.42e-05 | 195 | 139 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.52e-05 | 196 | 139 | 6 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.52e-05 | 196 | 139 | 6 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 196 | 139 | 6 | 558324d7779463fd5cd438aee7d0f86be7366d3f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 197 | 139 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 197 | 139 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 197 | 139 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.93e-06 | 194 | 138 | 9 | 2780_UP | |
| Drug | MMDA | 7.49e-06 | 7 | 138 | 3 | DB01442 | |
| Drug | 4-Methoxyamphetamine | 7.49e-06 | 7 | 138 | 3 | DB01472 | |
| Drug | Methamphetamine | 2.53e-05 | 10 | 138 | 3 | DB01577 | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A | 2.57e-05 | 195 | 138 | 8 | 5117_DN | |
| Drug | sulindac; Down 200; 50uM; MCF7; HG-U133A | 2.87e-05 | 198 | 138 | 8 | 307_DN | |
| Drug | I 1100 | 3.65e-05 | 2 | 138 | 2 | CID000013067 | |
| Drug | trimethyl citrate | 3.65e-05 | 2 | 138 | 2 | CID000074112 | |
| Drug | Pargyline | 3.65e-05 | 2 | 138 | 2 | DB01626 | |
| Drug | tribulin | 3.65e-05 | 2 | 138 | 2 | ctd:C039776 | |
| Drug | Isocarboxazid | 3.65e-05 | 2 | 138 | 2 | DB01247 | |
| Drug | NSC310407 | 3.65e-05 | 2 | 138 | 2 | CID000171344 | |
| Drug | C05636 | 3.65e-05 | 2 | 138 | 2 | CID000440736 | |
| Drug | 4,8-quinolinediol | 3.65e-05 | 2 | 138 | 2 | CID000440737 | |
| Drug | Tranylcypromine | 3.65e-05 | 2 | 138 | 2 | DB00752 | |
| Drug | ethyl 4-hydroxyphenylacetate | 3.65e-05 | 2 | 138 | 2 | CID000028310 | |
| Drug | AC1L2OJZ | 3.65e-05 | 2 | 138 | 2 | CID000125421 | |
| Drug | 5HAA | 3.65e-05 | 2 | 138 | 2 | CID000128291 | |
| Drug | methyl indole-3-propionate | 3.65e-05 | 2 | 138 | 2 | CID000021711 | |
| Drug | 3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one | 3.65e-05 | 2 | 138 | 2 | ctd:C492672 | |
| Drug | 2-chloroquinoxaline | 3.65e-05 | 2 | 138 | 2 | CID000238938 | |
| Drug | Selegiline | 3.65e-05 | 2 | 138 | 2 | DB01037 | |
| Drug | 1 mm PP | 3.65e-05 | 2 | 138 | 2 | CID000132866 | |
| Drug | Ephedra | 4.61e-05 | 12 | 138 | 3 | DB01363 | |
| Drug | GBR 12909 | 6.26e-05 | 69 | 138 | 5 | CID000003455 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.31e-05 | 355 | 132 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.83e-05 | 15 | 132 | 3 | DOID:14250 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 4.95e-05 | 45 | 132 | 4 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.95e-05 | 45 | 132 | 4 | EFO_0004623, EFO_0004792 | |
| Disease | Antithrombotic agent use measurement | 1.09e-04 | 55 | 132 | 4 | EFO_0009925 | |
| Disease | smoking cessation | 1.12e-04 | 325 | 132 | 8 | EFO_0004319 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.17e-04 | 56 | 132 | 4 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | phospholipids in small VLDL measurement | 1.54e-04 | 60 | 132 | 4 | EFO_0022146 | |
| Disease | L lactate dehydrogenase measurement | 2.11e-04 | 26 | 132 | 3 | EFO_0004808 | |
| Disease | Severe major depression with psychotic features | 2.94e-04 | 6 | 132 | 2 | C0270458 | |
| Disease | kallikrein‐6 measurement | 2.94e-04 | 6 | 132 | 2 | EFO_0010622 | |
| Disease | uridine measurement | 3.95e-04 | 32 | 132 | 3 | EFO_0010546 | |
| Disease | Parkinson Disease | 5.85e-04 | 85 | 132 | 4 | C0030567 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 7.43e-04 | 239 | 132 | 6 | EFO_0010934 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 8.73e-04 | 10 | 132 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 9.47e-04 | 43 | 132 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Mental Depression | 1.02e-03 | 254 | 132 | 6 | C0011570 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.06e-03 | 11 | 132 | 2 | C1335302 | |
| Disease | total lipids in very small VLDL measurement | 1.08e-03 | 45 | 132 | 3 | EFO_0022156 | |
| Disease | Malignant neoplasm of breast | XIRP1 MAOA PPM1E MFSD9 SLC2A5 JAG2 PPP1R3A PTPN14 SYNJ2 PPM1F AFF1 LGR6 HSD17B8 | 1.08e-03 | 1074 | 132 | 13 | C0006142 |
| Disease | Autistic Disorder | 1.17e-03 | 261 | 132 | 6 | C0004352 | |
| Disease | free cholesterol in very small VLDL measurement | 1.23e-03 | 47 | 132 | 3 | EFO_0022275 | |
| Disease | Cardiomyopathy | 1.23e-03 | 47 | 132 | 3 | cv:C0878544 | |
| Disease | Huntington Disease, Late Onset | 1.27e-03 | 12 | 132 | 2 | C0393574 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 1.27e-03 | 12 | 132 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 1.27e-03 | 12 | 132 | 2 | C0751208 | |
| Disease | familial hyperlipidemia | 1.34e-03 | 106 | 132 | 4 | MONDO_0001336 | |
| Disease | Alcoholic Intoxication, Chronic | 1.34e-03 | 268 | 132 | 6 | C0001973 | |
| Disease | phospholipids in medium LDL measurement | 1.39e-03 | 49 | 132 | 3 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 1.39e-03 | 49 | 132 | 3 | EFO_0022224 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.39e-03 | 49 | 132 | 3 | EFO_0022256 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.42e-03 | 713 | 132 | 10 | EFO_0005689 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.50e-03 | 13 | 132 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.50e-03 | 13 | 132 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.50e-03 | 13 | 132 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.50e-03 | 13 | 132 | 2 | C0019147 | |
| Disease | phospholipids in very small VLDL measurement | 1.56e-03 | 51 | 132 | 3 | EFO_0022300 | |
| Disease | lipoprotein A measurement | 1.64e-03 | 112 | 132 | 4 | EFO_0006925 | |
| Disease | phospholipids in medium VLDL measurement | 1.65e-03 | 52 | 132 | 3 | EFO_0022154 | |
| Disease | total lipids in medium LDL | 1.65e-03 | 52 | 132 | 3 | EFO_0022180 | |
| Disease | Hypotension | 1.74e-03 | 53 | 132 | 3 | C0020649 | |
| Disease | cholesterol in small VLDL measurement | 1.74e-03 | 53 | 132 | 3 | EFO_0022228 | |
| Disease | total lipids in medium VLDL | 1.84e-03 | 54 | 132 | 3 | EFO_0022153 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.94e-03 | 55 | 132 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Depressive disorder | 1.96e-03 | 289 | 132 | 6 | C0011581 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.04e-03 | 56 | 132 | 3 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.04e-03 | 56 | 132 | 3 | EFO_0022279 | |
| Disease | Schizophrenia | MCHR1 MAOA MAOB CSMD2 ADAMTS12 JAG2 SLC18A2 CSMD1 TNXB CNP SLC23A3 | 2.10e-03 | 883 | 132 | 11 | C0036341 |
| Disease | fibrinogen measurement, factor VII measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | uterine prolapse | 2.29e-03 | 16 | 132 | 2 | EFO_1001864 | |
| Disease | pancreatitis | 2.29e-03 | 16 | 132 | 2 | EFO_0000278 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 2.29e-03 | 16 | 132 | 2 | C1257877 | |
| Disease | phospholipids in VLDL measurement | 2.37e-03 | 59 | 132 | 3 | EFO_0022301 | |
| Disease | Liver Cirrhosis, Experimental | 2.58e-03 | 774 | 132 | 10 | C0023893 | |
| Disease | Huntington Disease | 2.58e-03 | 17 | 132 | 2 | C0020179 | |
| Disease | triacylglycerol 48:1 measurement | 2.58e-03 | 17 | 132 | 2 | EFO_0010404 | |
| Disease | free cholesterol in VLDL measurement | 2.61e-03 | 61 | 132 | 3 | EFO_0022276 | |
| Disease | free cholesterol in very large HDL measurement | 2.73e-03 | 62 | 132 | 3 | EFO_0022273 | |
| Disease | polyunsaturated fatty acid measurement | 2.89e-03 | 131 | 132 | 4 | EFO_0010733 | |
| Disease | Hypercholesterolemia, Familial | 2.90e-03 | 18 | 132 | 2 | C0020445 | |
| Disease | Coronary Arteriosclerosis | 3.12e-03 | 65 | 132 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 3.12e-03 | 65 | 132 | 3 | C1956346 | |
| Disease | Pheochromocytoma | 3.23e-03 | 19 | 132 | 2 | C0031511 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 3.26e-03 | 66 | 132 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | thyroid stimulating hormone measurement | 3.40e-03 | 323 | 132 | 6 | EFO_0004748 | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.40e-03 | 67 | 132 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.48e-03 | 225 | 132 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 3.70e-03 | 69 | 132 | 3 | EFO_0022341 | |
| Disease | alcohol consumption measurement | HGFAC CPNE8 KIF26A WNT4 CSMD3 BIRC6 TENM2 MST1R PTPRJ PEAK1 CSMD1 ABLIM2 ABCG8 | 3.84e-03 | 1242 | 132 | 13 | EFO_0007878 |
| Disease | lung cancer | 3.94e-03 | 21 | 132 | 2 | MONDO_0008903 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 4.01e-03 | 71 | 132 | 3 | EFO_0022259 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.06e-03 | 144 | 132 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | lifestyle measurement | 4.19e-03 | 235 | 132 | 5 | EFO_0010724 | |
| Disease | triacylglycerol 58:9 measurement | 4.33e-03 | 22 | 132 | 2 | EFO_0010443 | |
| Disease | complement factor H-like 1 protein measurement | 4.33e-03 | 22 | 132 | 2 | EFO_0600092 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GATLGTATSILALCG | 11 | Q7L8C5 | |
| SILCSGAQRDSGLVS | 821 | Q14146 | |
| NSLVTLSVCSGLRGT | 71 | Q6NVV9 | |
| GASVNITCSTSGGLR | 41 | P09564 | |
| LSCIGQRSLSNSGVL | 2121 | Q9NR09 | |
| RGSSGGGVSCIIRNS | 211 | O00478 | |
| IATCGGTLSTLGGVI | 1971 | Q96PZ7 | |
| ACGGTLRGQSGIISS | 201 | Q7Z408 | |
| ELNGSRIRTCTINGT | 3206 | Q7Z407 | |
| LTALGLLSCANTRTG | 201 | P45844 | |
| LLSCANTRTGSLSGG | 206 | P45844 | |
| LLGSISGGTDIISCF | 431 | Q86V21 | |
| SGCASGSGRQLQLSV | 51 | Q96LS8 | |
| TCRGIRGLITVSSNL | 131 | Q9H013 | |
| SGLGSLVGLSCVTRF | 871 | P33076 | |
| VSTLGEGTFGRVVQC | 166 | P49760 | |
| IFALSSGQGRCGIAV | 36 | Q969Y2 | |
| SGQGRCGIAVIRTSG | 41 | Q969Y2 | |
| HTLSSRLLTGCVGGS | 6 | Q12887 | |
| LAIIGSSGCGRASLL | 101 | Q9H221 | |
| LSQGLRSCGGCGTEI | 146 | Q6H8Q1 | |
| LSQSILTGGNHLCGT | 461 | Q8N6M6 | |
| GSVNGLCSRASLVTS | 631 | O43299 | |
| NITVLASDQGGRTCT | 546 | Q02487 | |
| GRTCTGTLGIILQDV | 556 | Q02487 | |
| CSVSCGGGVRIRSVT | 956 | P58397 | |
| VCIGATSGLGRLVSG | 361 | P36021 | |
| NAGIRCILGSAEGTL | 446 | Q5T481 | |
| ILGVAGSLVSGSCSQ | 16 | Q9Y5K2 | |
| GCQAIVDTGTSLLTG | 271 | P0DJD9 | |
| EIGTLSRCLNAGSGT | 361 | Q08999 | |
| CGGTTRIFSVTNGGQ | 201 | P21397 | |
| QCGGTTRIISTTNGG | 191 | P27338 | |
| LTLRGCQLGDAGTVT | 1416 | O75147 | |
| NGTASCRVLLESIGS | 231 | Q12913 | |
| LGRCGSSQSIRVATV | 306 | Q6IF00 | |
| GCGNSLRTALINSTG | 521 | P02545 | |
| VTCSGAGNGRNVSSL | 271 | Q9P2G4 | |
| ICINSSLNSSLGGAG | 16 | Q96JK9 | |
| SSITLERRLGTGCFG | 261 | P09769 | |
| GRTCITDLQLTVGGA | 391 | Q8NBP5 | |
| VGAIAGANTLTGISC | 601 | Q9HBX8 | |
| GANTLTGISCGLLAS | 606 | Q9HBX8 | |
| LALVGSARSEGVQTC | 16 | P78333 | |
| VGCGSGAISLSLLSQ | 166 | Q9Y5R4 | |
| TTVGAICSGIRSLPA | 986 | Q9Y219 | |
| TAGGSLRSIQRSLLC | 231 | Q96BI3 | |
| GGTTVGLLTICLTVI | 3116 | Q5SZK8 | |
| LLGSGTVIGSNCFIT | 361 | Q13144 | |
| GALCFGITGSLSIIS | 91 | Q9GZW8 | |
| VTLGTLGTNFGRCVD | 346 | Q8NBP7 | |
| GTGLESGTRIQSVLC | 176 | Q9Y233 | |
| GKQDGRGCTSVTTAL | 1066 | Q9H792 | |
| ACTRIKNSGLAGGLT | 646 | Q13608 | |
| TARITCGGNNIGSKS | 36 | P80748 | |
| GRLAGCTVFITGASR | 6 | Q6YN16 | |
| TARNTGIICTIGPAS | 41 | P14618 | |
| TASATTRVGCARLGQ | 1216 | Q9ULI4 | |
| GSVVARGGSLTLQCR | 231 | O75023 | |
| LSTGVLRSNGGCSIV | 461 | Q9NSB4 | |
| LRSNGGCSIVGTGEL | 466 | Q9NSB4 | |
| LGSIVSINCGDSLGV | 6 | Q96F86 | |
| GAGLSSVRFICGTQS | 96 | O75600 | |
| TCILLRGDQTTGGQA | 41 | Q96S07 | |
| ATTNVRPGTVCLLSG | 121 | A4D1T9 | |
| GRCGSSQSIRVATVI | 306 | Q8NGX2 | |
| ISLCSTGSLGSLGSL | 3116 | Q9Y4D8 | |
| LNGGTCHLIVATGTT | 251 | Q04756 | |
| RLAGLNICTSGSATS | 21 | P18084 | |
| TRSTAGLGLVCGLLA | 71 | Q96ES6 | |
| GCQAIVDTGTSLLTG | 271 | P0DJD8 | |
| RTVLISGCSSGIGLE | 6 | Q9NYR8 | |
| SGCSSGIGLELAVQL | 11 | Q9NYR8 | |
| GGITGQVCSSRTGNV | 611 | Q16821 | |
| LRCGTTGVVTFIRGN | 326 | Q8WY54 | |
| GSGIGASCVSLLTLS | 286 | Q9NZ94 | |
| TCRTSVGVAVLGGFL | 401 | Q9Y2M5 | |
| CVLGASSGNLRTFVG | 21 | Q86YW7 | |
| TGIGSTVILSCALTG | 326 | Q8TD84 | |
| TRGLCVLSVGANLTT | 5231 | Q9Y6R7 | |
| DQLIRNSGSGTCLTS | 586 | Q8NCL4 | |
| RTGSSICGSLNTLQD | 166 | Q8TF40 | |
| ALVSNGCRGSIINIS | 141 | Q92506 | |
| GALRCRGQSISVTSI | 821 | P10643 | |
| RLEVGSTQLRTAGSC | 51 | O95236 | |
| TQGSRKGGALQSCTI | 406 | P09543 | |
| LLACEGGTGTCVRVT | 121 | Q9GZN8 | |
| FGTICLLGIIGNSTV | 116 | Q99705 | |
| LSVSGRGSCCGQLAL | 376 | Q9NT22 | |
| LSCNTEIGVGVSRSS | 1591 | P35556 | |
| GLAGRESTATLLGCN | 686 | Q9NVP4 | |
| ALGTFQGTLACVLGS | 316 | Q86YV9 | |
| CLSGVGSLLGSSLVA | 501 | Q8IY34 | |
| VFCTLGEIVGSQGSR | 116 | Q86YQ8 | |
| CGAALTGTSISQVPR | 21 | Q9BQ95 | |
| LQSGTTGVCALIAGA | 251 | P49593 | |
| GCQAIVDTGTSLLTG | 271 | P0DJD7 | |
| GCALSQGSLRTGTQE | 416 | Q9NZT2 | |
| CVGALAGLSTQGTAR | 631 | Q13423 | |
| CSNVTIIRIGTSGGI | 131 | Q16831 | |
| GGVFRNGTCTSRITT | 376 | P30872 | |
| CLIRNTRGFLSSGGS | 101 | Q93075 | |
| CTITRSGLTGLVIGG | 101 | Q9H061 | |
| SGGTSLSFLVLVTGC | 71 | O15056 | |
| CSVRGGEELVLTGSN | 596 | Q14934 | |
| GARETCNGSLTLALG | 56 | Q8WTR8 | |
| RGLNVSCLSVQGSAS | 186 | Q9Y2G5 | |
| SRLLVGICAGVSSNV | 131 | P22732 | |
| QAGLVGCLLETLSTG | 491 | Q6ZNJ1 | |
| AVAGNTTVLCRLCGG | 56 | Q8NGU9 | |
| GRTGGQALSTLECVK | 1876 | P58107 | |
| CSAGVGRTGVLILSE | 1121 | Q15678 | |
| EGTGVCVLTGAALTI | 506 | Q9BZQ2 | |
| AGTITPTIGRCNISL | 1796 | Q9NT68 | |
| TKTGNAGSRLACGVI | 136 | P00441 | |
| ACSRGLSLEGLGSVL | 351 | Q6PIS1 | |
| GSGSRTSGCRQAVVV | 716 | P51825 | |
| FCTSLQGLLGSIAGV | 136 | Q9UBD9 | |
| VRSVNTGRSCVLGSN | 101 | Q8N9Z0 | |
| AASCGLQVVSTRVGG | 321 | P37287 | |
| SLGTAGRVCNLTSRG | 286 | P09544 | |
| ACATSGSSRLGRIGQ | 2336 | O15027 | |
| RGLGSLAVGAVTCDI | 271 | Q96MK2 | |
| STNIVSVCRATGLGP | 101 | O15067 | |
| QAGTGQTDVRTLCSL | 131 | P22105 | |
| GTRVSLSTICLLNGF | 131 | Q9GZP7 | |
| CRNTSGILGFSVTVG | 966 | O43847 | |
| CLTGAGCGVLSSTLR | 96 | P13489 | |
| CGGVIRNATTGRIVS | 416 | Q53EL9 | |
| LIGLSGVLTVGSSRC | 1246 | Q9NY15 | |
| GNCVSVGITALTLRA | 4111 | Q86WI1 | |
| RGVSIGTTCLLSVFQ | 91 | Q7Z5H5 | |
| LGSVRTLLQGSGCLA | 3481 | Q15149 | |
| LCLLGAGSVETGVTQ | 11 | A0A0C4DH59 | |
| LTGTGVCRSLRSGNE | 256 | Q9NWS9 | |
| GSTTAICATGLRNLG | 151 | Q9Y6I4 | |
| TLHCGNISGLRGQVT | 41 | Q8N0Z9 | |
| SGVLGTRGRTCNKTS | 286 | P56705 | |
| CRRGSSLGQISGASK | 901 | Q01118 | |
| LIARSLQGIGSSCSS | 186 | Q05940 | |
| RCGFLGSGSISLVTV | 61 | Q6DKI7 | |
| RAGGTCLTLEGQSLS | 696 | Q04912 | |
| LLACGLGTSVARTGL | 881 | Q702N8 | |
| ISLAIGGVTEGICTA | 76 | Q96FV9 | |
| VGRGVSIGSTCLLSV | 171 | Q8NFZ6 | |
| IGAVNVCVSSSRGGV | 421 | Q14533 | |
| RASSQTSLGGTICRV | 56 | P54296 |